Characteristics by User Group | Time Period of Opioid Use | Mean Use | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan-June 2008 | July-Dec 2008 | Jan-June 2009 | July-Dec 2009 | Jan-June 2010 | July-Dec 2010 | ||||||||
Mean | Median | Mean | Median | Mean | Median | Mean | Median | Mean | Median | Mean | Median | ||
All users* | |||||||||||||
Days of use | |||||||||||||
Group 1 | 8 | 5 | 8 | ||||||||||
Group 2 | 16 | 6 | 14 | 6 | 15 | ||||||||
Group 3 | 26 | 10 | 28 | 10 | 21 | 9 | 25 | ||||||
Group 4 | 40 | 16 | 43 | 20 | 42 | 20 | 33 | 15 | 40 | ||||
Group 5 | 50 | 25 | 55 | 30 | 55 | 30 | 53 | 30 | 37 | 20 | 50 | ||
Group 6 | 98 | 92 | 107 | 114 | 110 | 120 | 115 | 128 | 115 | 130 | 116 | 132 | 110 |
Daily dosage (MME) | |||||||||||||
Group 1 | 52 | 37.5 | 52 | ||||||||||
Group 2 | 50 | 37.5 | 50 | 38 | 50 | ||||||||
Group 3 | 50 | 36 | 50 | 36 | 48 | 37 | 49 | ||||||
Group 4 | 50 | 35 | 50 | 35 | 50 | 35 | 50 | 35 | 50 | ||||
Group 5 | 53 | 35 | 52 | 35 | 52 | 34 | 52 | 34 | 50 | 33 | 52 | ||
Group 6 | 72 | 38 | 74 | 39 | 75 | 40 | 77 | 40 | 79 | 40 | 80 | 40 | 76 |
Daily users† | |||||||||||||
Days of use | |||||||||||||
Group 1 | 134 | 137 | 134 | ||||||||||
Group 2 | 138 | 145 | 76 | 60 | 107 | ||||||||
Group 3 | 142 | 150 | 116 | 120 | 66 | 57 | 108 | ||||||
Group 4 | 147 | 153 | 130 | 146 | 112 | 120 | 76 | 60 | 116 | ||||
Group 5 | 148 | 160 | 137 | 150 | 125 | 144 | 115 | 127 | 70 | 60 | 119 | ||
Group 6 | 157 | 167 | 154 | 168 | 151 | 166 | 154 | 169 | 150 | 166 | 150 | 168 | 153 |
Daily dosage (MME) | |||||||||||||
Group 1 | 54 | 34 | 54 | ||||||||||
Group 2 | 70 | 39 | 66 | 38 | 68 | ||||||||
Group 3 | 69 | 37 | 69 | 37 | 61 | 36 | 66 | ||||||
Group 4 | 74 | 40 | 75 | 40 | 75 | 40 | 71 | 39 | 74 | ||||
Group 5 | 83 | 41 | 80 | 41 | 83 | 40 | 81 | 40 | 72 | 38 | 80 | ||
Group 6 | 101 | 46 | 105 | 47 | 108 | 48 | 111 | 50 | 113 | 51 | 114 | 51 | 109 |
Data from Truven Health MarketScan.
↵* Among all users, group 1 included 474,211 patients; group 2, 104,602 patients; group 3, 37,062 patients; group 4, 19,481 patients; group 5, 12,302 patients; and group 6, 141,799 patients. Total number of patients was 789,457.
↵† Among daily users, group 1 included 1,026 patients; group 2, 2,255 patients; group 3, 1,988 patients; group 4, 2,033 patients; group 5, 1,885 patients; and group 6, 62,066 patients. Total number of patients was 71,253.
MME, morphine milligram equivalent.